Skip to content

Cerevance

  • Platform
  • Tissue Collection
  • Pipeline
  • Team
    • Leadership
    • Advisors
    • Board
    • Investors
  • News
    • Press Releases
    • Media Coverage
  • Careers
  • Contact

News

Press Releases

January 27, 2023

Cerevance Announces Publication in Organic Process Research and Development

January 24, 2023

Cerevance to Participate at the SVB Global Biopharma Conference

January 9, 2023

Cerevance Announces Positive Topline Data from Phase 1 Clinical Trial of CVN766 for the Potential Use in the Treatment of Schizophrenia

December 7, 2022

Cerevance to Present at the RBC Capital Markets Virtual Healthcare Private Company Conference

November 30, 2022

Cerevance Announces Presentation of Preclinical Data During the Cold Spring Harbor Laboratory (CSHL) Neurodegenerative Diseases – Biology and Therapeutics Conference and Publication in Neuropharmacology

November 15, 2022

Cerevance Announces Presentation of Preclinical Study Results at the Society for Neuroscience Conference

November 7, 2022

Cerevance to Present at the Society for Neuroscience (SFN) 2022

October 3, 2022

Cerevance Appoints Ottavio V. Vitolo, M.D., as Chief Medical Officer

August 9, 2022

Cerevance Establishes Strategic Research Collaboration with Merck for the Discovery of Novel Targets in Alzheimer’s Disease

June 16, 2022

Cerevance to Present During the 5th Annual LSX World Congress USA

  • 1
  • 2
  • 3
  • 4

View Media Coverage

Cerevance
  • Platform
  • Tissue Collection
  • Pipeline
  • Team
  • News
  • Careers
  • Contact
Copyright Cerevance 2023